Glenmark Life Sciences dips on Glenmark Pharma’s plan to exit
Glenmark Life Sciences (GLS) shares dipped over 4 per cent, ending the day at ₹842.85, on the BSE, following the
Continue readingThe Number One Finance & Business Blog!
Glenmark Life Sciences (GLS) shares dipped over 4 per cent, ending the day at ₹842.85, on the BSE, following the
Continue readingGlenmark Specialty SA of Glenmark Pharmaceutical has received final approval from the United States Food & Drug Administration (USFDA) for
Continue readingGlenmark initiated Class II recall of the drug across the US on March 26 this year | File image 2
Continue readingShares of Glenmark Pharmaceuticals slipped 3 per cent to Rs 802.25 on the BSE during Friday’s trade after the
Continue readingLupine has been in the news lately. After last week’s massive approval of gSpiriva HandiHaler, there have been media reports
Continue readingGlenmark Pharmaceuticals on Friday reported a consolidated net loss of Rs. 403 crore for the March 2023 quarter due to
Continue reading